BackgroundClinical guidelines commonly recommend preventive treatments for people above a risk-threshold. Therefore, decision-makers must have faith in risk-prediction tools and model-based cost-effectiveness analyses for people at different levels of risk. Two problems that arise are inadequate...

This paper studies the design of the optimal non linear taxation in an economy where longevity varies across agents, and depends on three factors: longevity genes, health investment and farsightedness. Provided earnings, farsightedness and genes are correlated, governmental intervention can be...